Adèle Richart

768 total citations
16 papers, 518 citations indexed

About

Adèle Richart is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Adèle Richart has authored 16 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Adèle Richart's work include Chemokine receptors and signaling (3 papers), MicroRNA in disease regulation (3 papers) and Cardiac Ischemia and Reperfusion (3 papers). Adèle Richart is often cited by papers focused on Chemokine receptors and signaling (3 papers), MicroRNA in disease regulation (3 papers) and Cardiac Ischemia and Reperfusion (3 papers). Adèle Richart collaborates with scholars based in Australia, France and United Kingdom. Adèle Richart's co-authors include Jean‐Sébastien Silvestre, José Vilar, Alice Récalde, Bernard Lévy, Coralie L. Guérin, Yasmine Zouggari, Clément Cochain, Xavier Loyer, Lucie Poupel and Christophe Combadière and has published in prestigious journals such as Circulation, Circulation Research and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Adèle Richart

16 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adèle Richart Australia 9 300 132 126 126 90 16 518
Mathilde Lemitre France 11 362 1.2× 192 1.5× 171 1.4× 108 0.9× 156 1.7× 15 685
Ihab Abd‐Elrahman Israel 8 181 0.6× 111 0.8× 115 0.9× 83 0.7× 109 1.2× 11 443
Maarten M. Brandt Netherlands 17 280 0.9× 72 0.5× 170 1.3× 117 0.9× 109 1.2× 22 674
Cheng‐Nan Chen Taiwan 9 262 0.9× 150 1.1× 79 0.6× 76 0.6× 121 1.3× 12 656
Xiaoli Ma Canada 14 286 1.0× 187 1.4× 94 0.7× 84 0.7× 44 0.5× 25 544
Konstantina‐Ioanna Sereti United States 7 318 1.1× 142 1.1× 90 0.7× 119 0.9× 59 0.7× 10 472
Anna Skorska Germany 13 262 0.9× 111 0.8× 118 0.9× 73 0.6× 58 0.6× 31 481
Marine Bignon France 7 284 0.9× 52 0.4× 174 1.4× 160 1.3× 52 0.6× 8 564
Teresa Mancuso Italy 12 238 0.8× 166 1.3× 136 1.1× 79 0.6× 63 0.7× 16 486
Céline Loinard France 12 292 1.0× 73 0.6× 85 0.7× 130 1.0× 206 2.3× 16 594

Countries citing papers authored by Adèle Richart

Since Specialization
Citations

This map shows the geographic impact of Adèle Richart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adèle Richart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adèle Richart more than expected).

Fields of papers citing papers by Adèle Richart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adèle Richart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adèle Richart. The network helps show where Adèle Richart may publish in the future.

Co-authorship network of co-authors of Adèle Richart

This figure shows the co-authorship network connecting the top 25 collaborators of Adèle Richart. A scholar is included among the top collaborators of Adèle Richart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adèle Richart. Adèle Richart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Richart, Adèle, Anna C. Calkin, & Bronwyn A. Kingwell. (2021). Apolipoprotein A-I for Cardiac Recovery Post–Myocardial Infarction. JACC Basic to Translational Science. 6(9-10). 768–771. 3 indexed citations
2.
Richart, Adèle, Sarah Heywood, Andrew L. Siebel, et al.. (2020). Apo AI Nanoparticles Delivered Post Myocardial Infarction Moderate Inflammation. Circulation Research. 127(11). 1422–1436. 40 indexed citations
3.
Richart, Adèle, et al.. (2019). Abstract 329: ApoA-I nanoparticles (CSL-111) Directly Modulates Inflammatory Cells After Myocardial Infarction in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 39(Suppl_1). 1 indexed citations
4.
Richart, Adèle, et al.. (2018). Abstract 344: Reconstituted High-density Lipoprotein (rHDL) Directly Modulates Inflammatory Cells after Myocardial Infarction in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 38(Suppl_1). 1 indexed citations
5.
Heywood, Sarah, Adèle Richart, Darren C. Henstridge, et al.. (2017). High-density lipoprotein delivered after myocardial infarction increases cardiac glucose uptake and function in mice. Science Translational Medicine. 9(411). 44 indexed citations
6.
Kervadec, Anaïs, Valérie Bellamy, Nadia El Harane, et al.. (2016). Cardiovascular progenitor–derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. The Journal of Heart and Lung Transplantation. 35(6). 795–807. 144 indexed citations
7.
Kingwell, Bronwyn A., Sarah Heywood, Adèle Richart, et al.. (2016). HDL modulates cardiac glucose metabolism and inflammation and improves cardiac function after myocardial ischemia-reperfusion injury. Atherosclerosis. 252. e251–e251. 1 indexed citations
8.
Richart, Adèle, Sarah Heywood, Medini Reddy-Luthmoodoo, et al.. (2015). Abstract 17001: Reconstituted High-density Lipoprotein (CSL-111) Infusion Improves Post-ischemic Heart Function Through Modulating the Acute Inflammatory Response and Angiogenesis. Circulation. 132(suppl_3). 1 indexed citations
9.
Richart, Adèle, Xavier Loyer, Tui Néri, et al.. (2014). 0221: MicroRNA-21 coordinates human multipotent cardiovascular progenitors therapeutic potential and post-ischemic revascularization. Archives of Cardiovascular Diseases Supplements. 6. 21–21. 1 indexed citations
10.
Richart, Adèle, Xavier Loyer, Tui Néri, et al.. (2014). MicroRNA-21 Coordinates Human Multipotent Cardiovascular Progenitors Therapeutic Potential. Stem Cells. 32(11). 2908–2922. 29 indexed citations
11.
Cochain, Clément, Constance Auvynet, Lucie Poupel, et al.. (2012). The Chemokine Decoy Receptor D6 Prevents Excessive Inflammation and Adverse Ventricular Remodeling After Myocardial Infarction. Arteriosclerosis Thrombosis and Vascular Biology. 32(9). 2206–2213. 73 indexed citations
12.
Loinard, Céline, Yasmine Zouggari, Patricia Rueda, et al.. (2012). C/EBP Homologous Protein-10 (CHOP-10) Limits Postnatal Neovascularization Through Control of Endothelial Nitric Oxide Synthase Gene Expression. Circulation. 125(8). 1014–1026. 39 indexed citations
13.
Rueda, Patricia, Adèle Richart, Alice Récalde, et al.. (2012). Homeostatic and Tissue Reparation Defaults in Mice Carrying Selective Genetic Invalidation of CXCL12/Proteoglycan Interactions. Circulation. 126(15). 1882–1895. 53 indexed citations
14.
Récalde, Alice, Adèle Richart, Coralie L. Guérin, et al.. (2012). Sympathetic Nervous System Regulates Bone Marrow–Derived Cell Egress Through Endothelial Nitric Oxide Synthase Activation. Arteriosclerosis Thrombosis and Vascular Biology. 32(3). 643–653. 30 indexed citations
15.
Cochain, Clément, Mathieu P. Rodero, José Vilar, et al.. (2010). Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization. Cardiovascular Research. 88(1). 186–195. 57 indexed citations
16.
Richart, Adèle, et al.. (1964). [MEASURE OF PLASMA RESISTANCE TO LYSIS BY STREPTOKINASE. APPLICATION TO PATHOLOGIC THROMBOSIS. NEW TECHNIQUE FOR THE MEASUREMENT OF ACTIVATION OF PLASMINOGEN INHIBITORS].. PubMed. 41(6). 447–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mathilde Lemitre Breakdown of academic impact, for papers by Ihab Abd‐Elrahman Breakdown of academic impact, for papers by Maarten M. Brandt Breakdown of academic impact, for papers by Cheng‐Nan Chen Breakdown of academic impact, for papers by Xiaoli Ma Breakdown of academic impact, for papers by Konstantina‐Ioanna Sereti Breakdown of academic impact, for papers by Anna Skorska Breakdown of academic impact, for papers by Marine Bignon Breakdown of academic impact, for papers by Teresa Mancuso Breakdown of academic impact, for papers by Céline Loinard
Rankless by CCL
2026